Solid Biosciences Competitors, Revenue, Alternatives and Pricing

Claim your profile


Boston, MA USA
Total Funding:$366.3M
Lead Investor(s):J.P. Morgan, Goldman Sachs & Co. LLC

Estimated Revenue & Financials

  • Solid Biosciences's estimated annual revenue is currently $12.4M per year.(?)
  • Solid Biosciences received $133.7M in venture funding in February 2018.
  • Solid Biosciences's estimated revenue per employee is $120,388
  • Solid Biosciences's total funding is $366.3M.

Employee Data

  • Solid Biosciences has 103 Employees.(?)
  • Solid Biosciences grew their employee count by -34% last year.
  • Solid Biosciences currently has 1 job openings.

Solid Biosciences (Solid) is a Cambridge, MA based biotech company singularly focused on developing treatments and cures for Duchenne muscular dystrophy (DMD). Solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. Condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of DMD.